Impact of dyslipidemia associated with Highly Active Antiretroviral Therapy (HAART) on cardiovascular risk and life expectancy
- 1 March 2005
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 95 (5) , 586-591
- https://doi.org/10.1016/j.amjcard.2004.11.004
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Dose-ranging, randomized, clinical trial of atazanavir with lamivudine and stavudine in antiretroviral-naive subjectsAIDS, 2003
- Vascular complications associated with use of HIV protease inhibitorsThe Lancet, 1998
- Severe premature coronary artery disease with protease inhibitorsThe Lancet, 1998
- Estimating the Benefits of Modifying Risk Factors of Cardiovascular DiseaseArchives of internal medicine (1960), 1998
- The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol LevelsNew England Journal of Medicine, 1996
- An updated coronary risk profile. A statement for health professionals.Circulation, 1991
- Published by Massachusetts Medical Society ,1990
- Primary Prevention With Metoprolol in Patients With HypertensionJAMA, 1988
- The Lipid Research Clinics Coronary Primary Prevention Trial ResultsJAMA, 1984
- Lipoprotein-cholesterol distributions in selected North American populations: the lipid research clinics program prevalence study.Circulation, 1980